Evaluation of new high pH stable, superficially-porous particle columns for the reversed-phase separation of oligonucleotides
Posters | 2015 | Agilent Technologies | HPLC SymposiumInstrumentation
The development of synthetic oligonucleotides as therapeutic agents necessitates rapid and high-resolution analytical methods to detect and quantify N-1 and N-2 deletion impurities arising from coupling failures. High-pH mobile phases at elevated temperatures offer improved separation but require chemically stable stationary phases.
This study evaluates high-pH stable superficially-porous particle columns (AdvanceBio Oligonucleotide, 2.7 µm) for reversed-phase HPLC separation of RNA and DNA oligonucleotides. Performance metrics such as resolution, backpressure, analysis time, and column stability are compared with conventional totally porous C18 columns and hybrid particle phases. Both UV and LC/MS-compatible mobile phase systems are investigated.
Superficially-porous columns demonstrated narrower peak widths and shorter mass transfer distances, achieving baseline resolution of N and N-1 oligonucleotide impurities (21-mer RNA, 20-mer RNA) within 11–13 min at pressures around 108 bar versus 292 bar for competitor 1.7 µm C18. DNA ladder separation (15–40 mers) completed in under 10 min, with the 15-mer eluting at ~2 min and mid-length species around 4–5 min. MS-compatible conditions yielded the 25-mer DNA oligo and its impurities in ~3 min with clear resolution.
Column stability tests over 300–400 consecutive injections showed retention time reproducibility and maintained resolution, affirming the long lifetime of these high-pH stable columns.
Further integration with high-throughput LC-MS workflows and automation can streamline oligonucleotide analysis. Miniaturized column formats and AI-driven method optimization may enhance sensitivity and throughput. Expanding to modified nucleic acids and longer sequences will support next-generation oligonucleotide therapeutics.
AdvanceBio Oligonucleotide superficially-porous particle columns offer rapid, high-resolution, and robust separation of RNA and DNA oligonucleotides under high-pH conditions. Their low backpressure, extended lifetime, and compatibility with UV and MS detection make them well suited for research, QA/QC, and therapeutic development applications.
HPLC, Consumables, LC columns
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Summary
Importance of the Topic
The development of synthetic oligonucleotides as therapeutic agents necessitates rapid and high-resolution analytical methods to detect and quantify N-1 and N-2 deletion impurities arising from coupling failures. High-pH mobile phases at elevated temperatures offer improved separation but require chemically stable stationary phases.
Aims and Overview of the Study
This study evaluates high-pH stable superficially-porous particle columns (AdvanceBio Oligonucleotide, 2.7 µm) for reversed-phase HPLC separation of RNA and DNA oligonucleotides. Performance metrics such as resolution, backpressure, analysis time, and column stability are compared with conventional totally porous C18 columns and hybrid particle phases. Both UV and LC/MS-compatible mobile phase systems are investigated.
Methodology and Instrumentation Used
- Columns: AdvanceBio Oligonucleotide superficially-porous particles (2.1×50, 2.1×100, 2.1×150, and 4.6×50, 4.6×100, 4.6×150 mm; 2.7 µm), with fast guard cartridges.
- Mobile phases: A) 100 mM triethylammonium acetate (TEAA) in water and 100 mM TEAA in acetonitrile; B) LC/MS-friendly: 400 mM hexafluoroisopropanol (HFIP):15 mM triethylamine (TEA) in water and methanol mix.
- Gradient programs: e.g., 10–14% B in 10 min for RNA, 7–11% B in 5 min then to 80% B for DNA ladder.
- Instrument: Agilent 1290 Infinity Binary (and compatibility with 1260 Infinity Quaternary) HPLC systems; UV detection at 260 nm; column temperature 65 °C; flow rates 0.6 mL/min.
Main Results and Discussion
Superficially-porous columns demonstrated narrower peak widths and shorter mass transfer distances, achieving baseline resolution of N and N-1 oligonucleotide impurities (21-mer RNA, 20-mer RNA) within 11–13 min at pressures around 108 bar versus 292 bar for competitor 1.7 µm C18. DNA ladder separation (15–40 mers) completed in under 10 min, with the 15-mer eluting at ~2 min and mid-length species around 4–5 min. MS-compatible conditions yielded the 25-mer DNA oligo and its impurities in ~3 min with clear resolution.
Column stability tests over 300–400 consecutive injections showed retention time reproducibility and maintained resolution, affirming the long lifetime of these high-pH stable columns.
Benefits and Practical Applications
- Fast, high-resolution separation of RNA and DNA oligonucleotides for therapeutic development and QC.
- Low backpressure enabling use on both 600 bar and 1200 bar HPLC platforms.
- Robust performance under high-pH conditions and elevated temperatures.
- Compatibility with UV and MS detection workflows for method flexibility.
Future Trends and Potential Applications
Further integration with high-throughput LC-MS workflows and automation can streamline oligonucleotide analysis. Miniaturized column formats and AI-driven method optimization may enhance sensitivity and throughput. Expanding to modified nucleic acids and longer sequences will support next-generation oligonucleotide therapeutics.
Conclusion
AdvanceBio Oligonucleotide superficially-porous particle columns offer rapid, high-resolution, and robust separation of RNA and DNA oligonucleotides under high-pH conditions. Their low backpressure, extended lifetime, and compatibility with UV and MS detection make them well suited for research, QA/QC, and therapeutic development applications.
Reference
- Bidlingmeyer BA, Wang X, Luke S, Duong PT. Evaluation of new high pH stable superficially-porous particle columns for the reversed-phase separation of oligonucleotides. Agilent Technologies Application Note PSB-BIOAN-07; HPLC 2015.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Efficient Reversed-Phase Separation of Oligonucleotides by Using High pH Stable Superficially Porous Columns
2016|Agilent Technologies|Posters
Efficient Reversed-Phase Separation of Oligonucleotides by Using High pH Stable Superficially Porous Columns Agilent Technologie, Inc. Comparison with other columns Resolution of N and N-1 Oligonucleotides Separation of 23-mer RNA-oligonucleotide (2.1 x 50 mm) 21-mer mAU 14 15 N N-1…
Key words
oligonucleotides, oligonucleotidessuperficially, superficiallyporous, porousadvancebio, advancebiomin, minparticles, particlesoligonucleotide, oligonucleotidedna, dnasee, seeretention, retentionrna, rnacolumn, columncolumns, columnsconfidentiali, confidentialiminoligonucleotide
Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides
2017|Agilent Technologies|Applications
Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides High-pH-stable, superficially porous particle columns for LC/UV and LC/MS Application Note Biologics and Biosimilars Authors Introduction Phu Duong, Brian A. Bidlingmeyer, Synthetic DNA- and RNA-based oligonucleotides are among many successful biotherapeutic drugs…
Key words
ttttt, tttttoligonucleotide, oligonucleotideadvancebio, advancebiooligonucleotides, oligonucleotidesrna, rnadna, dnamau, maumin, minnmole, nmoleladder, laddersequence, sequenceretention, retentioncolumn, columnsuperficially, superficiallyteaa
Agilent AdvanceBio Oligonucleotide Columns and Oligonucleotide Standards
2015|Agilent Technologies|Brochures and specifications
Agilent AdvanceBio Oligonucleotide Columns and Oligonucleotide Standards IMPROVE RELIABILITY. REDUCE COSTS. INCREASE FLEXIBILITY. AGILENT ADVANCEBIO OLIGONUCLEOTIDE COLUMNS AND OLIGONUCLEOTIDE STANDARDS HIGH-RESOLUTION OLIGONUCLEOTIDE SEPARATIONS WITH LONG COLUMN LIFETIME ON HPLC AND UHPLC SYSTEMS Synthetic oligonucleotides are promising therapeutic agents for the…
Key words
oligonucleotide, oligonucleotideadvancebio, advancebioseparations, separationsagilent, agilentmau, mauoligonucleotides, oligonucleotidesoligo, oligotriethylammonium, triethylammoniumlifetime, lifetimerna, rnacolumns, columnsteaa, teaahexafluoroisopropanol, hexafluoroisopropanoldna, dnaresolution
Oligonucleotide Analysis: Practical Techniques and Method Development Optimization for HPLC
2023|Agilent Technologies|Presentations
Oligonucleotide Analysis: Practical Techniques and Method Development Optimization for HPLC Mohit Patel LC Columns and Consumables Technical Support December 19, 2023 1 12/19/2023 DE # DE48216954 What Are Oligonucleotide Therapeutic Types? Oligonucleotides are being increasingly developed as therapeutics against a…
Key words
oligonucleotide, oligonucleotideoligonucleotides, oligonucleotidesadvancebio, advancebiopair, pairladder, ladderbuffer, bufferresolution, resolutionmau, maurcrarcrurgrararurarcrcrararu, rcrarcrurgrararurarcrcrararurgrurcrarurcrarcrarcrurgrararurarcrcrararu, rgrurcrarurcrarcrarcrurgrararurarcrcrararururcrarcrarcrurgrararurarcrcrararu, rurcrarcrarcrurgrararurarcrcrararururcrarurcrarcrarcrurgrararurarcrcrararu, rurcrarurcrarcrarcrurgrararurarcrcrararuion, ionphase, phasebinding